Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome

NCT07577518 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

2301

Enrollment

OTHER

Sponsor class

Conditions

Chronic Coronary Syndrome

Interventions

PROCEDURE: percutaneous coronary intervention
DRUG: Guideline-directed Optimal Medical treatment
DRUG: Carvedilol Sustained-Release (SR) (Nested RCT subset)
DRUG: Carvedilol Immediate-Release (IR) (Nested RCT subset)

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]